Windy Giddens, NP
Adult Health · Valdosta, GANPI 1720451982
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 74.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $1,047 and has fallen 82.4% since, to $184 in 2025.
Across 28 payments — averaging $55.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1K
- Vertos Medical, Inc.$100
- Globus Medical$75
- Medtronic$59
- Spinal Simplicity, LLC$46
- Vertex$27
- plus $86 from 4 others
What the payments were for
- Travel & lodging$36924%
- Food & beverage$65442%
- Education$52834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 13 | $1,158 |
| Vertos Medical, Inc. | 1 | $100 |
| Globus Medical | 3 | $75 |
| Medtronic | 3 | $59 |
| Spinal Simplicity, LLC | 3 | $46 |
| Vertex | 1 | $27 |
| Biotronik NRO, Inc. | 1 | $26 |
| Abbott | 1 | $22 |
| Almatica Pharma LLC | 1 | $20 |
| Painteq LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$984
- mild Device Kit$100
How this compares
$1,552 in reported general payments places this provider in the 70th percentile of 577 adult health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 32 | $14,126 |
| LinzessLinaclotide | 16 | $12,919 |
| Pregabalin | 777 | $12,223 |
| Gabapentin | 546 | $6,949 |
| Duloxetine Hcl | 398 | $4,146 |
| Lidocaine | 42 | $3,263 |
| Diclofenac Sodium | 55 | $2,917 |
| Celecoxib | 175 | $2,782 |
| Cyclobenzaprine Hcl | 344 | $2,658 |
| Amitriptyline Hcl | 322 | $2,328 |
| Tramadol Hcl | 321 | $2,218 |
| Tizanidine Hcl | 227 | $2,009 |
| Sulindac | 88 | $1,388 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 76 | $1,254 |
| Ropinirole Hcl | 99 | $1,185 |
Paid to pharmacies, not to this prescriber.
Other adult health in Valdosta
- Dakshaben ColemanValdosta$9K
- Abbey VandermeidValdosta$8K
- Joshua BatsonValdosta$8K
- Christine BrownValdosta$7K
- Lisa WeldonValdosta$5K
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.